Oral Presentation 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases 2017

The Fiji rheumatic fever information system innovation to strengthen disease control (#54)

Samantha M Colquhoun 1 , Laisiana Matatolu 2 , Artika Kumari 3 , Shivnay Naidu 3 , Devina Nand 3 , Daniel Engelman 1 , Catherine Jackson 4 , Elizabeth C Kennedy 2 5 , Joseph H Kado 6
  1. Murdoch Childrens Research Institute and University of Melbourne, Parkville, VICTORIA, Australia
  2. Wellness Unit, Fiji Ministry of Health and Medical Services, Suva, Fiji
  3. Health Information Unit, Fiji Ministry of Health and Medical Services, Suva, Fiji
  4. Auckland District Health Board, Auckland, New Zealand
  5. Cure Kids , Suva, Fiji
  6. Paediatrics, FIji National University, Suva, Fiji


Fiji has had a limited register based RHD programme since 2005. To expand and enhance capability of the programme to provide clinical and epidemiological reports nationally, a collaboration with Ministry of Health and external partners developed the first web enabled national disease register with the ability to link to the  Ministry of Health electronic medical record system.

The Rheumatic Fever Information System (RFIS) was launched in 2016 following 18 months of development. The RFIS provides health professionals with easy access to patient clinical data and disease status. The first quarter reporting period in 2017 has shown the programme is now able to provide up to date information that can assist the MoHMS to target medication adherence, ensure timely clinical review, describe trends in epidemiology and identify vulnerable and at risk sub-populations. The RFIS has 3689 patients registered nationally (ARF n=302, RHD n= 3387, 33 % aged <18 years), 60% are iTaukei (Indigenous Fijians) and 21% Fijians of Indian descent. In 2016 there were 46 deaths with RHD attributed as the causal factor.

A 2012 audit found that only 12% of patients were receiving adequate adherence rates. The RFIS now collects and reports data on a quarterly basis from all clinics nationally. Results are reported back to each clinic allowing activities to be directly targeted at clinics and individuals to improve adherence and support patients to receive protective levels of adherence. The RFIS provides an enhanced ability to monitor adherence and epidemiological data in real time.